Venture Capital

New grants from the American Psychological Foundation fund direct interventions for trans youth and trauma-affected families, moving psychology from theory to action.

Karma Automotive will use Factorial's advanced solid-state batteries in its Kaveya supercar, sparking a new chapter for American EV manufacturing and innovation.

New data reveals Orca-T cell therapy boosts survival and cuts complications in blood cancer, as the company prepares for a potential FDA approval this year.

A new initiative unites top scientists to study 'SuperAgers' and resilient brains, aiming to unlock the secrets of healthy aging and prevent Alzheimer's.

With a key hire from IBM Watson Health, health AI firm Briya is set to scale its federated data platform, aiming to solve healthcare's research bottleneck.

With backing from top VCs, Angitia Biopharmaceuticals is accelerating its novel treatments for osteoporosis and rare bone disorders. Here's why it matters.

Nullify lands $12.5M to deploy autonomous AI security engineers, aiming to solve the cyber talent gap by replacing manual work with merge-ready code.

Pluristyx and Solesis launch a 'three-in-one' kit with nearly 100% efficiency in iPSC transfection, tackling a major bottleneck in organoid research.

Everbright Digital hopes a 1-for-16 reverse stock split will save its Nasdaq listing, but the move raises questions about its metaverse-focused future.

A new contract gives Canadian municipalities streamlined access to robotic mowers, a high-tech solution for labor shortages and budget pressures.

For its tenth straight Games, Technogym will equip Milano Cortina 2026 with AI-driven gear, cementing its legacy as the force behind athletic excellence.

A new study reveals Exicure's burixafor mobilizes stem cells in one hour, promising to streamline cancer treatment and unlock future gene therapies.

With major drug approvals on the horizon, Nuvalent's leadership will detail its strategy for its next-gen cancer therapies at an influential investor summit.

VectorY Therapeutics adds seasoned biotech architect Kevin Pojasek to its board, signaling a strategic push to accelerate its novel therapies for ALS and Alzheimer's.

Backed by top VCs, Airrived emerges from stealth with its Agentic OS, a new platform designed to replace fragmented AI tools with autonomous intelligence.

One company is betting that the ultra-rich want more than just opulence, offering scripted adventures from Siberian science missions to private palace balls.

Futures designer Nick Foster joins Unlikely Collaborators to challenge prediction, urging us to examine the hidden biases that shape what we see as possible.

A new partnership between Verity and Bushel connects on-farm data to clean fuel markets, promising a new era of revenue for sustainable farming practices.

A new second-hand retailer is coming to Springfield, blending a founder's homecoming with a booming resale market and a mission to give back to the community.

SiTime acquires Renesas' timing business in a bold move to dominate the AI and datacenter market and accelerate its path to $1 billion in revenue.